InvestLog
ALNY Alnylam Pharmaceuticals, Inc. logo

ALNY Alnylam Pharmaceuticals, Inc.

Healthcare
$295.50-0.66%ClosedMarket Cap: $39.45B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

19

Dispositions

15

Buy/Sell Ratio

1.27

Net Shares

+15,626

Shares Acquired

30,786

Shares Disposed

15,160

Total Bought ($)

$0.00

Total Sold ($)

$14.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 22Sigal Charles ElliottdirectorSell1,441$298.481,441
Fri May 22Sigal Charles ElliottdirectorSell671$0.001,446
Fri May 22SCHULMAN AMY WdirectorSell1,802$298.481,802
Fri May 22SCHULMAN AMY WdirectorSell838$0.0024,049
Fri May 22Reitan Colleen FdirectorSell1,441$298.481,441
Fri May 22Reitan Colleen FdirectorSell671$0.001,446
Fri May 22PYOTT DAVID E IdirectorSell1,441$298.481,441
Fri May 22PYOTT DAVID E IdirectorSell671$0.001,582
Fri May 22KELLOGG PETER NdirectorSell1,441$298.481,441
Fri May 22KELLOGG PETER NdirectorSell671$0.001,446
Thu May 14SCHULMAN AMY WdirectorSell11,250$70.2023,211
Tue Apr 07McLaughlin Melissaofficer: Chief Human Resources OfficerSell359$317.4412,729
Tue Apr 07McLaughlin Melissaofficer: Chief Human Resources OfficerSell265$316.6113,088
Tue Apr 07McLaughlin Melissaofficer: Chief Human Resources OfficerSell245$322.8611,818
Tue Apr 07McLaughlin Melissaofficer: Chief Human Resources OfficerSell224$321.6412,063